← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Envivo Bio Inc
San Carlos, CA
$3,873,859
Total funding
4
Grants
Funding over time
peak $1.7M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,983,457 · 2
NSF$1,890,402 · 2
By mechanism
—$1,890,402 · 2
R33$1,761,638 · 1
R21$221,819 · 1
Investigators at Envivo Bio Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
SBIR Phase II: Non-Invasive Sampling and Analysis of the Human Gasstrointestinal (GI) Tract to Advance Inflammatory Bowel Disease Research$1,666,323
· FY2021 · TIP
Development and clinical evaluation of the CapScan gastrointestinal sampling device for metabolomics monitoring$597,424
R33 · FY2023 · CA
Development and clinical evaluation of the CapScan gastrointestinal sampling device for metabolomics monitoring$594,530
R33 · FY2025 · CA
Development and clinical evaluation of the CapScan gastrointestinal sampling device for metabolomics monitoring$569,684
R33 · FY2024 · CA
SBIR Phase I: CapScan: Non-Invasive Sampling and Analysis of the Human GI Tract to Advance Inflammatory Bowel Disease Research$224,079
· FY2020 · TIP
Development and clinical evaluation of the CapScan gastrointestinal sampling device for metabolomics monitoring$221,819
R21 · FY2022 · CA